Renal cell carcinoma with fibromyomatous stroma: Difference between revisions

Jump to navigation Jump to search
Michael (talk | contribs)
No edit summary
Michael (talk | contribs)
No edit summary
 
(8 intermediate revisions by the same user not shown)
Line 2: Line 2:


''Renal cell carcinoma with leiomyomatous stroma'' redirects here.
''Renal cell carcinoma with leiomyomatous stroma'' redirects here.
==General==
*Rare tumour: 12 in >500 renal cell carcinomas with clear cells.<ref name=pmid36592877/>


==Microscopic==
==Microscopic==
Line 23: Line 26:
===Comparison between some renal tumours with clear cells===
===Comparison between some renal tumours with clear cells===
{| class="wikitable sortable"  
{| class="wikitable sortable"  
!Tumour
!Tumour
!CA9
!CK7
!CK7
!CD10
!CD10
!CK34betaE12 (K903)
!CK34betaE12 (K903)
!GPNMB
![[GPNMB]]
|-
|-
|Clear cell renal cell carcinoma  
|Clear cell renal cell carcinoma  
| +ve box-like (complete membrane)
| -ve (may be focal)
| -ve (may be focal)
| +ve
| +ve
Line 36: Line 41:
|-
|-
|Clear cell papillary renal cell tumour  
|Clear cell papillary renal cell tumour  
| +ve cup-like
| +ve (diffuse)
| +ve (diffuse)
| -ve
| -ve
Line 41: Line 47:
| -ve<ref name=pmid37661807>{{cite journal |authors=Li H, Argani P, Halper-Stromberg E, Lotan TL, Merino MJ, Reuter VE, Matoso A |title=Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others |journal=Am J Surg Pathol |volume=47 |issue=11 |pages=1267–1273 |date=November 2023 |pmid=37661807 |doi=10.1097/PAS.0000000000002117 |url=}}</ref>
| -ve<ref name=pmid37661807>{{cite journal |authors=Li H, Argani P, Halper-Stromberg E, Lotan TL, Merino MJ, Reuter VE, Matoso A |title=Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others |journal=Am J Surg Pathol |volume=47 |issue=11 |pages=1267–1273 |date=November 2023 |pmid=37661807 |doi=10.1097/PAS.0000000000002117 |url=}}</ref>
|-
|-
|ELOC-mutated renal cell carcinoma
|ELOC-mutated renal cell carcinoma
| +ve box-like
| +ve
| +ve
| +ve
| +ve
Line 47: Line 54:
| -ve
| -ve
|-
|-
|TSC/mTOR-mutated renal cell carcinoma
|Renal cell carcinoma with fibromyomatous stroma
| +ve box-like or cup-like<ref name=pmid36611378>{{cite journal |authors=Stanca S, Boldrini L, Erba PA, Faviana P |title=Are Renal Cell Carcinoma with Fibromyomatous Stroma (RCC-FMS) and Thyroid-like Follicular Carcinoma of the Kidney (TLFCK) Really Independent Variants? |journal=Diagnostics (Basel) |volume=13 |issue=1 |pages= |date=December 2022 |pmid=36611378 |pmc=9818596 |doi=10.3390/diagnostics13010086 |url=}}</ref>
| +ve
| +ve
| +ve
| +ve
Line 54: Line 62:
|-
|-
|}
|}
==Molecular==
==Molecular==
*[[Renal neoplasms with TSC/mTOR pathway mutations|TSC/mTOR pathway mutation]].<ref name=pmid36592877/>
*[[Renal neoplasms with TSC/mTOR pathway mutations|TSC/mTOR pathway mutation]].<ref name=pmid36592877/>
**A somewhat non-specific finding as [[Renal neoplasms with TSC/mTOR pathway mutations|several renal tumours (with a different morphology) have TSC/mTOR pathway mutations]].
==Sign out==
===Molecular lacking===
<pre>
Right Kidney, Radical Nephrectomy:
    - RENAL CELL CARCINOMA with clear cells, cysts and leiomyomatous stroma, see comment.
    -- Margin clear.
    -- Please see synoptic report for details.
Comment:
The tumour stains as follows:
POSITIVE: CD10 (moderate), EMA (patchy), CK7 (diffuse), PAX8 (diffuse).
NEGATIVE: CK34betaE12, CK20.
The differential diagnosis includes: (1) clear cell renal cell carcinoma, (2) RCC with a mTOR pathway mutation, and (3) ELOC-mutated RCC.
</pre>


==See also==
==See also==